The goal of this proposal is to define the major immunologic, virologic, and genetic factors that are determinants of long-term survival in HIV disease. A consortium of experts has been brought together to conduct these studies. Fresh peripheral blood and lymphoid tissue and cryopreserved specimens from Multicenter AIDS Cohort Study donors will be examined. immunological and genetic aims focus on the role of HIV- specific CD8+ T cell responses because they are the leading candidates for a host determinant of long-term survival. Studies on CD8+ T cell functions will be conducted on MACS donors at UCLA in the laboratory of the Principal Investigator. Genetic associations with long-term survival will be examined by Dr. Dean Mann (National Cancer Institute) in collaboration with this consortium. Drs. John Fahey and Otoniel Maritinez-Maza (UCLA) and Dr. Gene Shearer (National Cancer Institute) will receive specimens through this consortium to allow evaluation of the hypothesis that monokine and lymphokine dysregulation contribute to disease progression. Studies on the virologic determinants of long-term survival will be conducted at UCLA by Dr. Andrew Kaplan to investigate the hypotheses that viral load, replication potential, phenotype and genotype are determinants of the outcome of HIV infection. Overall guidance in the virologic studies will be provided by Dr. Irvin Chen in his role as the Director of the NIH-funded UCLA Center for AIDS Research. Dr. Ashley Haase (University of Minnesota Medical School) will contribute information on HIV infection in lymphoid tissues. Dr. Ronald Desrosiers (New England Regional Primate Research Center) will examine viral sequences from long-term survivor MACS subjects for alterations in their viral regulatory genes. Finally, Dr. Steven Wolinsky (Northwestern University Medical Center) will provide an interface between the studies conducted as a part of the NIH-funded Correlates of Immune Protection in AIDS Vaccine Recipients contract and this project. A number of hypotheses are being tested because multiple mechanisms may be involved in long-term survival. Host and viral determinants are likely to interact and are not mutually exclusive. The studies conducted will test a number of the leading hypotheses in order to define determinants of long-term survival.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI037613-04
Application #
2672466
Study Section
Special Emphasis Panel (SRC (70))
Project Start
1995-04-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
2000-03-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Tipton, Laura; Cuenco, Karen T; Huang, Laurence et al. (2018) Measuring associations between the microbiota and repeated measures of continuous clinical variables using a lasso-penalized generalized linear mixed model. BioData Min 11:12
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Anderegg, Nanina; Johnson, Leigh F; Zaniewski, Elizabeth et al. (2017) All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS 31 Suppl 1:S31-S40
Drozd, Daniel R; Kitahata, Mari M; Althoff, Keri N et al. (2017) Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr 75:568-576
Dubrow, Robert; Qin, Li; Lin, Haiqun et al. (2017) Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr 75:382-390
Jiamsakul, Awachana; Kariminia, Azar; Althoff, Keri N et al. (2017) HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr 76:319-329

Showing the most recent 10 out of 217 publications